Independent urology practices head into 2027 facing a conversion factor cut, prior authorization hurdles, and Part B drug price negotiation, according to Gary Kirsh, MD.
|Articles|February 6, 2020
Dr. Mara Holton discusses LUGPA's recent policy victories, upcoming challenges
Dr. Holton, vice chair of LUGPA's Health Policy Committee, spoke with Urology Times at the 2019 LUGPA annual meeting in Chicago.
Advertisement
Mara R. Holton, MD, vice chair of LUGPA's Health Policy Committee, spoke with Urology Times at the 2019 LUGPA annual meeting in Chicago.
Advertisement
Related to this article
The 2026 LUGPA Annual Meeting will tackle policy, artificial intelligence, and practice growth, according to Benjamin H. Lowentritt, MD, FACS.
Advertisement
Advertisement
Trending on Urology Times
1
Q&A: Gary Kirsh, MD, on health policy for independent urology
2
PTEN loss: From biomarker to treatment strategy in mHSPC
3
Suzanne B. Merrill, MD, on the evolving perioperative landscape in MIBC
4
Modern BCG outperforms historic benchmarks in high-risk NMIBC
5